Exact Sciences Corp., a Madison company developing a DNA-based, non-invasive test for colon cancer, said Tuesday it is trying to raise nearly $64 million in a stock offering. Read the full Milwaukee Journal Sentinel story here.
Journal Sentinel: Exact Sciences files to sell 5.5 million shares
by Tech Council | Jun 18, 2013 | Featured, NEWSROOM, Tech Council News